Seeing Is Believing
Currently out of the existing stock ratings of Dana Flanders, 25 are a BUY (67.57%), 11 are a HOLD (29.73%), 1 are a SELL (2.7%).
Analyst Dana Flanders, carries an average stock price target met ratio of 75.95% that have a potential upside of 20.72% achieved within 256 days. Previously, Dana Flanders worked at GOLDMAN SACHS.
Dana Flanders’s has documented 68 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VALN, Valneva SE ADR at 08-May-2025.
Analyst best performing recommendations are on ANIP (ANI PHARMACEUTICALS).
The best stock recommendation documented was for ANIP (ANI PHARMACEUTICALS) at 9/11/2019. The price target of $76 was fulfilled within 2 days with a profit of $6.36 (9.13%) receiving and performance score of 45.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$15
$5.84 (63.76%)
$15
1 months 16 days ago
(02-Sep-2025)
0/7 (0%)
$7.17 (91.57%)
Buy
$12
$2.84 (31.00%)
$8
11 months 12 days ago
(06-Nov-2024)
7/11 (63.64%)
$1 (9.09%)
23
Buy
$16
$6.84 (74.67%)
$23
1 years 1 months 6 days ago
(12-Sep-2024)
10/14 (71.43%)
$8.13 (103.30%)
134
Sell
$9
1 years 10 months 29 days ago
(19-Nov-2023)
2/3 (66.67%)
$0.88 (10.84%)
7
Hold
$15
$5.84 (63.76%)
$29
2 years 5 months ago
(18-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
Which stock is Dana Flanders is most bullish on?
What Year was the first public recommendation made by Dana Flanders?